Visit COVID-19 resources

[Skip to Content]

The All Party Parliamentary Group for Eye Health inquiry into lack of capacity report launches 6 June 2018

May 31
2018

The RCOphth has contributed to the All Party Parliamentary Group for Eye Health inquiry into the capacity issues affecting patients. The report will be launched at Parliament on 6 June and the success of the launch will be helped by having a good attendance of MPs. With this in mind, all members are kindly requested

  • 31 May 2018

SeeAbility launch new research report ‘Children in focus – a clear call to action’

May 02
2018

SeeAbility has released new research, ‘Children in focus – a clear call to action’, that suggests thousands of children with learning disabilities in England’s special schools are missing out on vital eye tests and eye care despite being 28 times more likely to have a serious sight problem than other children. Around 100,000 children attend special schools in England,

  • 2 May 2018

The Royal College of Ophthalmologists AGM 2018

Apr 05
2018

The 30th AGM of The Royal College of Ophthalmologists will be held on Tuesday, 22 May 2018 at 10.05am at Annual Congress, hosted at the Arena & Convention Centre (AAC), Liverpool. Please note that all members are entitled to attend the Annual General Meeting. Those members who are not registered for Congress but who wish to

  • 5 April 2018

The Royal College of Ophthalmologists release first National Data Set in Refractive Surgery

Mar 12
2018

Following the release of Professional Standards for Refractive Surgery and a comprehensive set of informative patient information in April 2017, the RCOphth has now released a national data set to be used by clinics offering refractive surgery. A national data set defines a standard set of information and data to be collected which is generated

  • 12 March 2018

RCOphth guideline: Hydroxychloroquine and Chloroquine Retinopathy: NEW screening recommendations February 2018

Mar 02
2018

The new guideline on screening for hydroxychloroquine and chloroquine retinopathy is written in response to evidence from the United States that shows that hydroxychloroquine retinopathy is more common than previously recognised. Implementation of the guideline’s recommendations will prevent iatrogenic visual loss. The new guideline also makes recommendations regarding the techniques and timing of baseline and

  • 2 March 2018